Amniotic Membrane Associated With Conjunctival Autograft Versus Conjunctival Autograft for Recurrent Pterygia
Phase 1
- Conditions
- Recurrent Pterygia
- Registration Number
- NCT00802620
- Lead Sponsor
- Federal University of São Paulo
- Brief Summary
The purpose of this study is to compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia.
- Detailed Description
Patients with recurrent pterygia without symblepharon were randomly assigned to undertake pterygium excision followed by amniotic membrane associated with a small conjunctival autograft (2x3mm) or conjunctival autograft (approximately 5x8mm) alone. The patients were examined after 1, 7, 30, 90, 180 and 360 days after the surgery. Recurrence was considered as a fibrovascular ingrowth of 1.5 mm or more beyond the limbus with conjunctival drag.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Recurrent pterygium
Exclusion Criteria
- Less than 15 year of age
- Symblepharon
- Glaucoma,
- Ocular Allergy
- Ocular surface disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Amniotic membrane treatment for recurrent pterygia one year
- Secondary Outcome Measures
Name Time Method